Explore 3 Stock Ideas & Industry Insights Download Free Report

Arcadia Biosciences Inc

Company price
0.155 USD -0.00 ( 0.64%)
Last update at 2026-11-03T21:00:00Z
VOLUME
111923
Market Cap
1.04M

Momentum Score

…

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.14
Low
0.16
High
52 Week Price Range
0.38
Low
5.72
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Arcadia Biosciences develops crop trait technologies intended to improve yield, stress tolerance and nutritional quality for agricultural markets. Long-term growth drivers include rising global food demand and climate-related pressure on crop productivity, which increase demand for resilient and higher-value seeds. The company may appeal to investors seeking exposure to agricultural biotechnology and trait-based solutions.
Key risks include execution and commercialization challenges—particularly regulatory approvals, market adoption against large seed and trait competitors, and the need for external financing to fund development and scale-up.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.16
Dividend Yield
-
Revenue TTM
4.75M
Revenue Per Share
2.43
Gross Profit TTM
1.64M
Debt / Equity
0.02
ROE
-430.93%
Net Debt
-0.26M
ROCE
-51.95%
Diluted EPS TTM
-4.54

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -2.33M -4.31M -5.32M -15.60M -16.13M
Minority interest - 0.00M 0.09M 0.24M 1.47M
Net income -2.34M -7.04M -13.98M -15.61M -16.13M
Selling general administrative 7.00M 9.64M 17.73M 18.05M 22.94M
Gross profit 1.76M 2.08M 2.28M 0.15M -1.93M
Reconciled depreciation 0.03M 0.11M 0.31M 0.48M 1.04M
Ebit -2.33M -7.61M -6.02M -19.40M -35.53M
Ebitda -2.30M -7.50M -5.73M -22.72M -18.36M
Depreciation and amortization 0.03M 0.11M 0.29M -3.32M 17.16M
Operating income -9.99M -3.65M -6.10M -19.40M -35.53M
Other operating expenses 14.85M 8.69M 10.56M 29.36M 35.53M
Interest expense - - - 0.29M 0.02M
Tax provision 0.01M 0.01M 0.01M 0.01M 0.00M
Interest income 0.22M 0.78M 0.69M - -
Net interest income 0.22M 0.78M 0.70M 0.29M -0.79M
Income tax expense 0.01M 0.01M 0.01M 0.01M 0.00M
Total revenue 4.86M 5.04M 4.45M 9.96M 6.78M
Total operating expenses 11.76M 5.73M 8.38M 19.56M 26.83M
Cost of revenue 3.10M 2.96M 2.17M 9.80M 8.71M
Total other income expense net 7.66M -0.66M 0.78M 3.81M 19.39M
Net income from continuing ops -2.34M -4.32M -18.51M -15.61M -16.13M
Net income applicable to common shares - - - - -14.66M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 6.55M 13.52M 19.70M 28.92M 43.92M
Intangible assets 0.04M 0.04M 0.04M 0.04M 0.48M
Other current assets 0.16M 2.92M 0.86M 0.81M 0.90M
Total liab 2.41M 7.29M 7.00M 8.02M 12.72M
Total stockholder equity 4.14M 6.22M 12.84M 21.03M 31.09M
Other current liab 0.61M 1.71M 1.94M 0.32M 0.26M
Common stock 0.07M 0.07M 0.07M 0.07M 0.06M
Capital stock 0.07M 0.07M 0.07M 0.07M 0.06M
Retained earnings -281.22M -278.88M -271.84M -257.86M -226.49M
Other liab - - - - 5.46M
Good will - - - - 0.00M
Other assets - - 0.00M - 2.67M
Cash 0.26M 4.24M 6.52M 20.64M 28.68M
Total current liabilities 2.06M 2.56M 3.59M 4.21M 5.04M
Current deferred revenue - - - - 0.06M
Net debt -0.26M -4.09M -5.51M -18.63M -25.39M
Short term debt - 0.15M 0.85M 1.01M 1.07M
Short long term debt total - 0.15M 1.01M 2.02M 3.29M
Other stockholder equity 285.29M 285.04M 284.51M 278.83M 257.51M
Property plant equipment - - - - 5.37M
Total current assets 6.36M 9.24M 14.97M 25.40M 35.39M
Net tangible assets - - - - 30.61M
Short term investments 4.30M 0.00M 5.12M - 0.00M
Net receivables 0.42M 1.18M 0.51M 1.29M 1.37M
Inventory 1.21M 0.90M 1.96M 2.57M 4.43M
Accounts payable 1.45M 0.70M 0.80M 2.88M 3.64M
Accumulated other comprehensive income - - 0.10M - -
Non currrent assets other 0.14M 4.06M 3.52M 0.93M 2.67M
Non current assets total 0.19M 4.28M 4.73M 3.52M 8.53M
Capital lease obligations 0.00M 0.15M 1.01M 2.02M 3.29M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00M 7.34M -4.12M 1.42M 16.61M
Change to liabilities - - - - -0.38M
Total cashflows from investing activities 0.75M 7.34M -4.34M - 16.61M
Net borrowings - - - - -2.15M
Total cash from financing activities 0.01M 0.01M 5.51M 4.52M 21.90M
Change to operating activities - - - - -1.46M
Net income -2.34M -4.32M -13.99M -15.61M -16.13M
Change in cash -3.98M -2.28M -14.13M -8.04M 12.64M
Begin period cash flow 4.24M 6.52M 20.64M 28.68M 16.04M
End period cash flow 0.26M 4.24M 6.52M 20.64M 28.68M
Total cash from operating activities -4.74M -9.63M -15.29M -13.98M -25.87M
Issuance of capital stock - 0.00M 6.00M 5.00M 25.15M
Depreciation 0.03M 0.77M 0.29M 0.48M 1.04M
Other cashflows from investing activities 0.75M 4.00M 0.12M - -
Change to inventory -0.31M 0.55M -2.42M 1.12M -2.38M
Change to account receivables 0.17M -0.76M 0.18M 0.59M -0.04M
Sale purchase of stock - - - - 25.15M
Other cashflows from financing activities 0.01M 0.01M -0.48M 0.45M -1.10M
Change to netincome - - - - -9.27M
Capital expenditures 0.00M 0.02M 0.01M 0.07M 1.01M
Change in working capital -0.03M -1.45M -2.74M 1.05M -2.92M
Stock based compensation 0.23M 0.51M 0.72M 1.11M 1.54M
Other non cash items -2.64M -4.63M 0.43M -1.00M 0.49M
Free cash flow -4.74M -9.64M -15.30M -14.05M -26.88M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RKDA
Arcadia Biosciences Inc
-0.00
0.64%
0.15 - 36.63 0.22 1.64 0.06 0.62
NSRGF
Nestle SA
3.65
3.63%
104.28 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR
-0.95
0.92%
102.44 26.82 18.66 3.18 7.07 3.81 21.70
DANOY
Danone PK
-0.12
0.81%
14.71 24.23 17.64 1.88 2.57 1.88 11.70
GPDNF
Danone S.A
-0.26
0.35%
73.62 20.30 14.75 1.65 2.24 1.76 10.92

Profile*

Arcadia Biosciences Inc

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

5956 Sherry Lane, Dallas, TX, United States, 75225

214 974 8921

8

Name Title Year Born
Ms. Pamela Haley CFO & Corp. Sec. 1971
Ms. Laura Pitlik Chief Marketing Officer 1974
Mr. Stanley E. Jacot Jr. Pres, CEO & Director 1970
Ms. Belinda Yao VP of Operations NA
Mr. Brian Schaffer Sr. VP of Sales NA
Mr. Kevin Hodges VP of Commercial Operations NA
Mr. Stanley E. Jacot Jr. President, CEO & Director 1971
Mr. Thomas J. Schaefer CFO & Corporate Secretary 1976
Mr. Tracy Baker Senior Vice President of Seamless Technical Operations NA
Mr. Thomas J. Schaefer C.F.A. CEO, Interim CFO, Principal Accounting Officer, President, Corporate Secretary & Director 1976

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…